(Date:5/12/2008)...cell AG (,Intercell,) to acquire Iomai Corporation...saction for USD 6.60 per share of Iomai,s common...f Iomai of approximately USD 189 million (EUR 12...h stock-for-stock exchange for approximately 41 pe...by major shareholders for,approximately 1.7 millio...
(Date:5/12/2008)...ORK, May 12 /PRNewswire-USNewswire/ -- The Allianc...its passage of a resolution,supporting the goals a...ins,annually on Mother,s Day. The resolution, intr...a Snowe (R-ME) calls on all Americans to take the,...ducate themselves on,women,s health issues, and re...
(Date:5/12/2008)...e cells adjust their function like a radio dial, n...at how autoimmune disease may develop,late in life.../ -- A St. Jude Children,s,Research Hospital study...lators, do not use simple on/off switches to gover...lopment and function. Rather, they,possess sophist...
(Date:5/12/2008)... show promising neurological recovery in severely-...atients treated with Cethrin, HOPKINTON, Mass., M...icals, Inc. (Nasdaq: ALSE ) today announced 12-mo...al of Cethrin, a proprietary recombinant,protein t...tore motor and,sensory function after spinal cord ...
Breaking Medicine Technology:Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5Campbell Alliance Business Development Practice Leader to Co Chair and Keynote at SRI Pharma Licensing Summit 7599 1Campbell Alliance Business Development Practice Leader to Co Chair and Keynote at SRI Pharma Licensing Summit 7599 2Campbell Alliance Business Development Practice Leader to Co Chair and Keynote at SRI Pharma Licensing Summit 7599 3HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 7596 1HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 7596 2HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 7596 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 979 1Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 979 2Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 979 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 979 4Allergy Foundation Thinks Globally Gifts Locally 7592 1Allergy Foundation Thinks Globally Gifts Locally 7592 2...ll.--(BUSINESS WIRE)--Apr 26, 2007 - Northfield,La...t its contract,research organization has informed ...om its pivotal Phase III trauma trial with,PolyHem...carrying,red cell substitute, will not be complete...field Laboratories Inc. is a leader in developing ...
...f Clinical Oncology publishes first clinical study...Newswire-FirstCall/ -- Human,Genome Sciences, Inc....ence continues to emerge demonstrating that its TR...d HGS-ETR2 (lexatumumab), have,significant potenti...ncers. , "We believe that HGS-ETR1 and HGS-ETR2 co...
Other Medicine Technology:Northfield Laboratories Investor Update 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5(Date:5/13/2008)... to discuss the benefits of Hemodiafiltration ther...al Disease Patients, NEW YORK, May 13 /PRNewswire...cal device company developing and marketing produc... End-Stage Renal Disease (ESRD) patient,while add...of the care,provider, today announced that it exhi...
(Date:5/13/2008)...D and TELIGEN(TM) ICD represent entirely new platf.../ -- Boston Scientific,Corporation (NYSE: BSX ) t...FDA) approval of its COGNIS(TM) cardiac resynchron...TM) implantable cardioverter,defibrillator (ICD). ...treat heart failure and sudden cardiac death and a...
(Date:5/13/2008)...an same as MRI, CT for false positives, study foun...- An advanced imaging technique to detect head an...ceiving an early or more accurate diagnosis of the...sion tomography with a radioactive tracer (18F-FDG...used to check whether head and neck squamous cell ...
(Date:5/13/2008)...Raguskus to Serve as Senior Technology Advisor, S...e Board of Directors,of Sonic Innovations, Inc. (N...ital hearing aids, today announced that Andrew Rag...r. Raguskus will continue as a member of the,Board...dvisor. As a result,of Mr. Raguskus, announcement,...
Breaking Medicine News(10 mins):Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 3Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 4Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4Health News:High-Tech Imaging No Better for Diagnosing Head/Neck Cancers 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 3...duction of unusual beer from cow's milk on a tip f...to put his milk surpluses to good use.// Beer bre... shelves Thursday, in the Japanese city of Nakashi...rthernmost island of Hokkaido. The production te...
...th by bleaching them, consult the right technician...uld cause considerable harm, warn// British doctor...ng by unqualified technicians, some of whom even u... president of the British Academy of Cosmetic Dent...
...developing world would benefit from better prepara...g the Health needs of the// poor’, a BMA report pu...tee surveyed 79 UK healthcare professionals, inclu...cently worked in Africa. Respondents identified ...
...earch Center have, for the first time, identified ...ightened risk //for Alzheimer's disease in adults,...ed newborns would develop cerebral palsy. This is... increases susceptibility to cerebral palsy. Resul...
Other Medicine News:Health News:Health Workers Need Better Preparation for Developing World 2Health News:Newborns' Cerebral Palsy Risk Increased By Alzheimer's Gene 2...zontal gel electrophoresis system is designed for ...fragments in agarose gels. This system allows the ...thern blotting of high quality. Complete system wi...aker Stands, (4) 52 x 60 mm Trays, (2) 107 x 60 mm...
...; consists of a Separation-Control unit for system...it for gel staining. The optional PhastTransfer Ki...ting unit. Electrophoresis is performed on a therm...accurately from 0 to +70 C. Multi-step programming...
...ratus and ready-to-use gels are the key components... by submerged gel electrophoresis. We provide othe...l compatibility and optimal performance, at a reas... staining tray, the system includes a power supply...
...tal gels offer many advantages for nucleic acid se...olecular biologist. Agarose gels are easy to cast ...e underlaying and prevent electrical field discont...n. Horizontal systems are more economical and easi...
Medicine Products: